Filing Details

Accession Number:
0002007919-24-000047
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-09-12 17:14:23
Reporting Period:
2024-09-10
Accepted Time:
2024-09-12 17:14:23
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
2007919 Inhibrx Biosciences Inc. INBX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1612627 Md Kristiina Vuori C/O Inhibrx Biosciences, Inc.
11025 N. Torrey Pines Road, Suite 140
La Jolla CA 92037
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-09-10 179 $15.00 7,319 No 4 P Direct
Common Stock Acquisiton 2024-09-11 6,457 $15.07 13,776 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Footnotes
  1. The shares were purchased in multiple transactions at prices ranging from $15.00 to $15.08, inclusive. The reported price reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.